Industry News II

Near Term Industry Analysis of US Therapeutic Discovery Programs: A Foretaste on What We can Expect from the US Life Science Industry in the Future – Press Releases

September 25, 2012 No Comments »

NEW YORK, Sept. 25, 2012 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue:

Near Term Industry Analysis of US Therapeutic Discovery Programs: A Foretaste on What We can Expect from the US Life Science Industry in the Future

http://www.reportlinker.com/p0587644/Near-Term-Industry-Analysis-of-US-Therapeutic-Discovery-Programs-A-Foretaste-on-What-We-can-Expect-from-the-US-Life-Science-Industry-in-the-Future.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

This analysis was initiated and is based on the U.S. Governments $1 Billion dollars Qualifying Therapeutic Discovery Project (QTDP) program. It was a competitive awards process with some 5,600 applications from nation-wide being reviewed by the US National Institutes of Health in 2010. The program was oversubscribed with about $10 Billion in requests. The QTDP program has generated a very unique and wide sampeling of what could be regarded as the very best of US life science industry. Ultimately 4,606 projects from 2,923 companies were deemed eligible. The grant arm of the QTDP program, representing 4,516 projects (98%), 2,844 companies (97%) and $981 Million dollars (98%), is by far the most dominating part of this initiative and is also the basis for the present analysis. The foundation for the analysis is based on research and interpreting all grant projects according to 57 life science categories*.

The second part has been to connect projects with proper company descriptions, including full contact details and company profile. Thirdly, as the relevance of the grant projects are tightly linked to the people involved, BioSeeker has included almost 15,000 key personnel associated with included companies.

The QTDP funding initiative has turned out to be an unprecedented US wide sampling of high quality therapeutic discovery projects. It represents a unique gathering of emerging small companies, where a hand full were incorporated as late as 2010. BioSeeker has created this analysis with 57 life science categories and integrated auxiliary data for you to:

* Find technologies , drugs and devices of value to your company

* Benchmark against competitors

* Find trends in the current market place

* Identify key personnel in companies

This analysis is presented to you as a html driven application in your browser and requires no installation. It lets you review, analyze and sample the included information by four different dynamic analysis sheets:

* By Company

* By Project

* By Life Science Category

* By State

To order this report:

Drug_Discovery_and_Development Industry: Near Term Industry Analysis of US Therapeutic Discovery Programs: A Foretaste on What We can Expect from the US Life Science Industry in the Future

Contact Nicolas: nicolasbombourg@reportlinker.com
US: (805)-652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker

Powered by WPeMatico

Leave A Response